Info

Aspira Biosystems is developing technology that enables the capture, with very high specificity, of targeted proteins. Aspira is actively seeking academic and commercial partners to develop therapeutic, medical research and industrial applications based on Partial Molecular Imprinting (PMI), our patented protein capture platform. Aspira is a wholly owned subsidiary of Nanomune Technologies, Inc. Nanomune's main shareholders are Archangel BioVentures, LLC and Alloy Ventures, Inc.